82_FR_42522 82 FR 42350 - Notice of Listing of Members of the National Institutes of Health's Senior Executive Service 2017 Performance Review Board (PRB)

82 FR 42350 - Notice of Listing of Members of the National Institutes of Health's Senior Executive Service 2017 Performance Review Board (PRB)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 172 (September 7, 2017)

Page Range42350-42351
FR Document2017-18899

The National Institutes of Health (NIH) announces the persons who will serve on the National Institutes of Health's Senior Executive Service 2017 Performance Review Board.

Federal Register, Volume 82 Issue 172 (Thursday, September 7, 2017) 
[Federal Register Volume 82, Number 172 (Thursday, September 7, 2017)]
[Notices]
[Pages 42350-42351]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-18899]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Notice of Listing of Members of the National Institutes of 
Health's Senior Executive Service 2017 Performance Review Board (PRB)

SUMMARY: The National Institutes of Health (NIH) announces the persons 
who will serve on the National Institutes of Health's Senior Executive 
Service 2017 Performance Review Board.

FOR FURTHER INFORMATION CONTACT: For further information about the NIH 
Performance Review Board, contact the Office of Human Resources, 
Division of Senior and Scientific Executive Management, National 
Institutes of Health, Building 2, Room 5E18, Bethesda, Maryland 20892, 
telephone 301-402-7999 (not a toll-free number).

SUPPLEMENTARY INFORMATION: This action is being taken in accordance 
with Title 5, U.S.C., Section 4314(c)(4), which requires that members 
of performance review boards be appointed in a manner to ensure

[[Page 42351]]

consistency, stability, and objectivity in performance appraisals and 
requires that notice of the appointment of an individual to serve as a 
member be published in the Federal Register.
    The following persons will serve on the NIH Performance Review 
Board, which oversees the evaluation of performance appraisals of NIH 
Senior Executive Service (SES) members:

Alfred Johnson, Chair
Joellen Austin
Michael Gottesman
Richard Ikeda
Michael Lauer
Ellen Rolfes
LaVerne Stringfield
Lawrence Tabak
Timothy Wheeles

    Dated: August 30, 2017.
Francis S. Collins,
Director, National Institutes of Health.
[FR Doc. 2017-18899 Filed 9-6-17; 8:45 am]
 BILLING CODE 4140-01-P

42350 Federal Register / Vol. 82, No. 172 / Thursday, September 7, 2017 / Notices 1271; Guidance for Industry.’’ Received for electronic access to the guidance Regulated Solely Under section 361 of comments will be placed in the docket document. the Public Health Service Act and 21 and, except for those submitted as FOR FURTHER INFORMATION CONTACT: CFR part 1271.’’ It does not establish ‘‘Confidential Submissions,’’ publicly Tami Belouin, Center for Biologics any rights for any person and is not viewable at https://www.regulations.gov Evaluation and Research, Food and binding on FDA or the public. You can or at the Dockets Management Staff Drug Administration, 10903 New use an alternative approach if it satisfies between 9 a.m. and 4 p.m., Monday Hampshire Ave., Bldg. 71, Rm. 7301, the requirements of the applicable through Friday. Silver Spring, MD 20993–0002, 240– statutes and regulations. This guidance • Confidential Submissions—To is not subject to Executive Order 12866. 402–7911. submit a comment with confidential information that you do not wish to be SUPPLEMENTARY INFORMATION: II. Paperwork Reduction Act of 1995 made publicly available, submit your I. Background This guidance refers to previously comments only as a written/paper approved collections of information submission. You should submit two FDA is announcing the availability of found in FDA regulations. These copies total. One copy will include the a document entitled ‘‘Deviation collections of information are subject to information you claim to be confidential Reporting for Human Cells, Tissues, and review by the Office of Management and with a heading or cover note that states Cellular and Tissue-Based Products Budget (OMB) under the Paperwork ‘‘THIS DOCUMENT CONTAINS Regulated Solely Under Section 361 of Reduction Act of 1995 (44 U.S.C. 3501– CONFIDENTIAL INFORMATION.’’ The the Public Health Service Act and 21 3520). The collections of information in Agency will review this copy, including CFR part 1271; Guidance for Industry.’’ 21 CFR part 1271 have been approved the claimed confidential information, in The document provides establishments under OMB control number 0910–0543. its consideration of comments. The that manufacture HCT/Ps, regulated solely under section 361 of the PHS Act III. Electronic Access second copy, which will have the claimed confidential information and the regulations under 21 CFR part Persons with access to the Internet redacted/blacked out, will be available 1271, with recommendations and may obtain the guidance at either for public viewing and posted on relevant examples for complying with https://www.fda.gov/ https://www.regulations.gov. Submit the requirements under 21 CFR BiologicsBloodVaccines/ both copies to the Dockets Management 1271.350(b) to investigate and report GuidanceComplianceRegulatory Staff. If you do not wish your name and HCT/P deviations. The examples Information/Guidances/default.htm or contact information to be made publicly provided in the guidance are intended https://www.regulations.gov. available, you can provide this to illustrate those HCT/P deviations that Dated: August 23, 2017. information on the cover sheet and not have been most frequently reported to Anna K. Abram, in the body of your comments and you FDA, CBER. Deputy Commissioner for Policy, Planning, must identify this information as The guidance does not apply to Legislation, and Analysis. ‘‘confidential.’’ Any information marked reproductive HCT/Ps or to HCT/Ps [FR Doc. 2017–18737 Filed 9–6–17; 8:45 am] as ‘‘confidential’’ will not be disclosed regulated under 21 CFR part 1270 and BILLING CODE 4164–01–P except in accordance with 21 CFR 10.20 recovered before May 25, 2005. The and other applicable disclosure law. For guidance does not apply to healthcare more information about FDA’s posting professionals who implant, transplant, DEPARTMENT OF HEALTH AND of comments to public dockets, see 80 infuse, or transfer HCT/Ps into HUMAN SERVICES FR 56469, September 18, 2015, or access recipients. The guidance also does not the information at: https://www.gpo.gov/ apply to HCT/Ps that are regulated as National Institutes of Health fdsys/pkg/FR-2015-09-18/pdf/2015- drugs, devices, and/or biological 23389.pdf. products under section 351 of the PHS Notice of Listing of Members of the Docket: For access to the docket to Act and/or the Federal Food, Drug, and National Institutes of Health’s Senior read background documents or the Cosmetic Act, nor does it apply to Executive Service 2017 Performance electronic and written/paper comments investigational HCT/Ps subject to an Review Board (PRB) received, go to https:// investigational new drug application or SUMMARY: The National Institutes of www.regulations.gov and insert the an investigational device exemption. Health (NIH) announces the persons docket number, found in brackets in the In the Federal Register of December who will serve on the National heading of this document, into the 24, 2015 (80 FR 80364), FDA announced Institutes of Health’s Senior Executive ‘‘Search’’ box and follow the prompts the availability of the draft guidance of Service 2017 Performance Review and/or go to the Dockets Management the same title dated December 2015. Board. Staff, 5630 Fishers Lane, Rm. 1061, FDA received a few comments on the Rockville, MD 20852. draft guidance and those comments FOR FURTHER INFORMATION CONTACT: For Submit written requests for single were considered as the guidance was further information about the NIH copies of the guidance to the Office of finalized. A summary of changes Performance Review Board, contact the Communication, Outreach and includes additional examples and Office of Human Resources, Division of Development, Center for Biologics editorial changes to improve clarity. The Senior and Scientific Executive Evaluation and Research (CBER), Food guidance announced in this notice Management, National Institutes of and Drug Administration, 10903 New finalizes the draft guidance dated Health, Building 2, Room 5E18, Hampshire Ave., Bldg. 71, Rm. 3128, December 2015. Bethesda, Maryland 20892, telephone mstockstill on DSK30JT082PROD with NOTICES Silver Spring, MD 20993–0002. Send This guidance is being issued 301–402–7999 (not a toll-free number). one self-addressed adhesive label to consistent with FDA’s good guidance SUPPLEMENTARY INFORMATION: This assist the office in processing your practices regulation (21 CFR 10.115). action is being taken in accordance with requests. The guidance may also be The guidance represents the current Title 5, U.S.C., Section 4314(c)(4), obtained by mail by calling CBER at 1– thinking of FDA on ‘‘Deviation which requires that members of 800–835–4709 or 240–402–8010. See Reporting for Human Cells, Tissues, and performance review boards be the SUPPLEMENTARY INFORMATION section Cellular and Tissue-Based Products appointed in a manner to ensure VerDate Sep<11>2014 17:42 Sep 06, 2017 Jkt 241001 PO 00000 Frm 00082 Fmt 4703 Sfmt 4703 E:\FR\FM\07SEN1.SGM 07SEN1

Federal Register / Vol. 82, No. 172 / Thursday, September 7, 2017 / Notices 42351 consistency, stability, and objectivity in Place: National Institutes of Health, Border Protection is designating an performance appraisals and requires Building 31, Conference Room 10, 31 Center approved Native American Tribal Card that notice of the appointment of an Drive, Bethesda, MD 20892. issued by the Pokagon Band of individual to serve as a member be Open: 10:00 a.m. to 3:00 p.m. Potawatomi Indians (Pokagon Band) to Agenda: A report from the Institute published in the Federal Register. Director and other staff. U.S. and Canadian citizens as an The following persons will serve on Place: National Institutes of Health, acceptable travel document for purposes the NIH Performance Review Board, Building 31, Conference Room 10, 31 Center of the Western Hemisphere Travel which oversees the evaluation of Drive, Bethesda, MD 20892. Initiative. The approved card may be performance appraisals of NIH Senior Contact Person: Partap Singh Khalsa, used to denote identity and citizenship Executive Service (SES) members: Ph.D., DC, Director, Division of Extramural of Pokagon Band members entering the Alfred Johnson, Chair Activities, National Center for United States from contiguous territory Joellen Austin Complementary and Integrative Health, NIH, or adjacent islands at land and sea ports Michael Gottesman National Institutes of Health, 6707 of entry. Richard Ikeda Democracy Blvd., Ste. 401, Bethesda, MD 20892–5475, (301) 594–3462, khalsap@ DATES: This designation will become Michael Lauer Ellen Rolfes mail.nih.gov. effective on September 7, 2017. LaVerne Stringfield Any interested person may file written FOR FURTHER INFORMATION CONTACT: Lawrence Tabak comments with the committee by forwarding Colleen Manaher, Executive Director, Timothy Wheeles the statement to the Contact Person listed on Planning, Program Analysis, and this notice. The statement should include the Dated: August 30, 2017. name, address, telephone number and when Evaluation, Office of Field Operations, Francis S. Collins, applicable, the business or professional U.S. Customs and Border Protection, via Director, National Institutes of Health. affiliation of the interested person. email at Colleen.M.Manaher@ In the interest of security, NIH has cbp.dhs.gov. [FR Doc. 2017–18899 Filed 9–6–17; 8:45 am] instituted stringent procedures for entrance SUPPLEMENTARY INFORMATION: BILLING CODE 4140–01–P onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles Background will be inspected before being allowed on DEPARTMENT OF HEALTH AND campus. Visitors will be asked to show one The Western Hemisphere Travel HUMAN SERVICES form of identification (for example, a Initiative government-issued photo ID, driver’s license, National Institutes of Health Section 7209 of the Intelligence or passport) and to state the purpose of their visit. Reform and Terrorism Prevention Act of National Center for Complementary Information is also available on the 2004 (IRTPA), Public Law 108–458, as and Integrative Health; Notice of Institute’s/Center’s home page: https:// amended, required the Secretary of Meeting nccih.nih.gov/about/naccih/, where an Homeland Security (Secretary), in agenda and any additional information for consultation with the Secretary of State, Pursuant to section 10(d) of the the meeting will be posted when available. to develop and implement a plan to Federal Advisory Committee Act, as (Catalogue of Federal Domestic Assistance require U.S. citizens and individuals for amended, notice is hereby given of a Program Nos. 93.213, Research and Training whom documentation requirements meeting of the National Advisory in Complementary and Integrative Health, have previously been waived under Council for Complementary and National Institutes of Health, HHS) section 212(d)(4)(B) of the Immigration Integrative Health. Dated: August 31, 2017. and Nationality Act (8 U.S.C. The meeting will be open to the Michelle Trout, 1182(d)(4)(B)) to present a passport or public as indicated below, with Program Analyst, Office of Federal Advisory other document or combination of attendance limited to space available. Committee Policy. documents as the Secretary deems Individuals who plan to attend and [FR Doc. 2017–18897 Filed 9–6–17; 8:45 am] sufficient to denote identity and need special assistance, such as sign citizenship for all travel into the United language interpretation or other BILLING CODE 4140–01–P States. See 8 U.S.C. 1185 note. On April reasonable accommodations, should 3, 2008, the Department of Homeland notify the Contact Person listed below DEPARTMENT OF HOMELAND Security (DHS) and the Department of in advance of the meeting. The meeting will be closed to the SECURITY State promulgated a joint final rule, public in accordance with the effective on June 1, 2009, that provisions set forth in sections U.S. Customs and Border Protection implemented the plan known as the 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Western Hemisphere Travel Initiative [CBP Dec. 17–11] (WHTI) at U.S. land and sea ports of as amended. The grant applications and the discussions could disclose entry. See 73 FR 18384 (the WHTI Land Western Hemisphere Travel Initiative: confidential trade secrets or commercial and Sea Final Rule). It amended various Designation of an Approved Native property such as patentable material, sections of the Code of Federal American Tribal Card Issued by the and personal information concerning Regulations (CFR), including 8 CFR Pokagon Band of Potawatomi Indians individuals associated with the grant 212.0, 212.1, and 235.1. The WHTI Land as an Acceptable Document To Denote applications, the disclosure of which and Sea Final Rule specifies the Identity and Citizenship for Entry in the would constitute a clearly unwarranted documents that U.S. citizens and United States at Land and Sea Ports of nonimmigrant aliens from Canada, mstockstill on DSK30JT082PROD with NOTICES invasion of personal privacy. Entry Bermuda, and Mexico are required to Name of Committee: National Advisory AGENCY: U.S. Customs and Border present when entering the United States Council for Complementary and Integrative at land and sea ports of entry. Health Protection; DHS. Date: October 6, 2017 ACTION: Notice. Under the WHTI Land and Sea Final Closed: 8:30 a.m. to 9:45 a.m. Rule, one type of citizenship and Agenda: To review and evaluate grant SUMMARY:This notice announces that identity document that may be applications the Commissioner of U.S. Customs and presented upon entry to the United VerDate Sep<11>2014 17:42 Sep 06, 2017 Jkt 241001 PO 00000 Frm 00083 Fmt 4703 Sfmt 4703 E:\FR\FM\07SEN1.SGM 07SEN1


Document Created: 2017-09-07 02:01:58
Document Modified: 2017-09-07 02:01:58
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ContactFor further information about the NIH Performance Review Board, contact the Office of Human Resources, Division of Senior and Scientific Executive Management, National Institutes of Health, Building 2, Room 5E18, Bethesda, Maryland 20892, telephone 301-402-7999 (not a toll-free number).
FR Citation82 FR 42350 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR